Time to reimbursement for orphan drugs in EU5 in the last five years
Comparison of Market Access Routes of Digital Health Applications in France, Germany and the UK
New digital health applications (DHA) reaching the health care market and some have already proven a clear benefit for patients through RCTs. But how is it with the market access: Different countries handle DHAs similar to other health care products, others have implemented a special pathway. The objective of this analysis is to examine DHA market access routes in Germany, France and the UK.